A Day Up For Vaxart, Inc.
Tue, Jan 21, 2020 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) rocketted at $0.53, representing a gain of 35.9%. On Mon 20 Jan 20, VXRT:NASDAQ touched a New 2-Week Intraday High of $0.41. From Fri 27 Dec 19, the stock recorded 42.86% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Genprex, Inc. (GNPX:NASDAQ), 219.44%
- NanoViricides, Inc. (NNVC:NYSEMKT), 152.98%
- CSS Industries, Inc. (CSS:NYSE), 100%
- Novavax, Inc. (NVAX:NASDAQ), 71.08%
- BioPharmX Corporation (BPMX:NYSEMKT), 59.57%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 47.95%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 39.88%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 38.57%
- iBio, Inc. (IBIO:NYSEMKT), 36.23%
- Vaxart, Inc. (VXRT:NASDAQ), 35.9%